InvestorsHub Logo
Followers 6
Posts 315
Boards Moderated 0
Alias Born 12/06/2013

Re: jbog post# 77505

Sunday, 10/16/2016 11:30:11 PM

Sunday, October 16, 2016 11:30:11 PM

Post# of 80490
Agree with all but your last point. Potential acquirers are focused primarily on Brigatinib. They need product, and Brigatinib is a valuable asset (assuming the data continues to be good).
Regarding Bernie, he did us all a service by pointing out certain problems, but his remedies were, as my two favorite philosophers, Click and Clack, might say, unencumbered by the thought process. Ditto his recent comments on ARIA. People would die without Pona, this is not a commodity drug.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.